F. Karimi and A. Arya, “SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients with Type 2 Diabetes: SGLT2 inhibitor-induced ketonemia in type 2 diabetes”, Iran J Pharm Sci, vol. 19, no. 2, pp. 176–187, Apr. 2023.